Original Article

Differential binding of proteins to peroxisomes in rat hepatoma cells: unique association of enzymes involved in isoprenoid metabolism

Correspondence to: Ishaiahu Shechter

Farnesyl diphosphate synthase (FPPS: EC2.5.1.10), a key enzyme in isoprenoid metabolic pathways, catalyzes the synthesis of farnesyl diphosphate (FPP) an intermediate in the biosynthesis of both sterol and non-sterol isoprenoid end products. The localization of FPPS to peroxisomes has been reported (Krisans, S. K., J. Ericsson, P. A. Edwards, and G. A. Keller. 1994. J. Biol. Chem. 269: 14165;–14169). Using indirect immunofluorescence and immunoelectron microscopic techniques we show here that FPPS is localized predominantly in the peroxisomes of rat hepatoma H35 cells. However, the partial release of 60;–70% of cellular FPPS activity is observed by selective permeabilization of these cells with digitonin. Under these conditions, lactate dehydrogenase, a cytosolic enzyme, is completely released whereas catalase, a known peroxisomal enzyme, is fully retained. Digitonin treatment of H35 cells differentially affects the release of other peroxisomal enzymes involved in isoprenoid metabolism. For instance, mevalonate kinase and phosphomevalonate kinase are almost totally released (95% and 91%, respectively), whereas 3-hydroxy-3-methylglutaryl-CoA reductase is fully retained. Indirect immunoflourescence studies indicate that FPPS is localized in peroxisomes of Chinese hamster ovary (CHO)-K1 cells but is dispersed in the cytosol of ZR-82 cells, a mutant that lacks peroxisomes. Unlike in H35 cells, FPPS is completely released upon digitonin permeabilization of CHO-K1 and ZR-82 cells. In contrast, under the same permeabilization conditions, catalase is fully retained in CHO-K1 cells but completely released from ZR-82 cells.

These studies indicate that FPPS and other enzymes in the isoprenoid biosynthetic pathways, involved in the formation of FPP, are differentially associated with peroxisomes and may easily diffuse to the cytosol. Based on these observations, the significance and a possible regulatory model in the formation of isoprenoid end-products are discussed.—Gupta, S. D., R. S. Mehan, T. R. Tansey, H-T. Chen, G. Goping, I. Goldberg, and I. Shechter. Differential binding of proteins to peroxisomes in rat hepatoma cells: unique association of enzymes involved in isoprenoid metabolism. J. Lipid Res. 1999. 40: 1572;–1584.

Supplementary key words: peroxisomes, cholesterol, isoprenoids, immunofluorescence, cellular permeabilization, farnesyl diphosphate synthase, catalase

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Laezza, M. Notarnicola, M. G. Caruso, C. Messa, M. Macchia, S. Bertini, F. Minutolo, G. Portella, L. Fiorentino, S. Stingo, et al. N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation FASEB J, March 1, 2006; 20(3): 412 - 418. [Abstract] [Full Text] [PDF]

				P. Leivar, V. M. Gonzalez, S. Castel, R. N. Trelease, C. Lopez-Iglesias, M. Arro, A. Boronat, N. Campos, A. Ferrer, and X. Fernandez-Busquets Subcellular Localization of Arabidopsis 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Plant Physiology, January 1, 2005; 137(1): 57 - 69. [Abstract] [Full Text] [PDF]

				S. Hogenboom, J. J. M. Tuyp, M. Espeel, J. Koster, R. J. A. Wanders, and H. R. Waterham Phosphomevalonate kinase is a cytosolic protein in humans J. Lipid Res., April 1, 2004; 45(4): 697 - 705. [Abstract] [Full Text] [PDF]

				S. Hogenboom, J. J. M. Tuyp, M. Espeel, J. Koster, R. J. A. Wanders, and H. R. Waterham Mevalonate kinase is a cytosolic enzyme in humans J. Cell Sci., February 15, 2004; 117(4): 631 - 639. [Abstract] [Full Text] [PDF]

				W. J. Kovacs, J. E. Shackelford, K. N. Tape, M. J. Richards, P. L. Faust, S. J. Fliesler, and S. K. Krisans Disturbed Cholesterol Homeostasis in a Peroxisome-Deficient PEX2 Knockout Mouse Model Mol. Cell. Biol., January 1, 2004; 24(1): 1 - 13. [Abstract] [Full Text] [PDF]

				L. Lefebvre, A. Vanderplasschen, V. Ciminale, H. Heremans, O. Dangoisse, J.-C. Jauniaux, J.-F. Toussaint, V. Zelnik, A. Burny, R. Kettmann, et al. Oncoviral Bovine Leukemia Virus G4 and Human T-Cell Leukemia Virus Type 1 p13II Accessory Proteins Interact with Farnesyl Pyrophosphate Synthetase J. Virol., February 1, 2002; 76(3): 1400 - 1414. [Abstract] [Full Text] [PDF]

				S. Hogenboom, G. J. Romeijn, S. M. Houten, M. Baes, R. J. A. Wanders, and H. R. Waterham Absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis J. Lipid Res., January 1, 2002; 43(1): 90 - 98. [Abstract] [Full Text] [PDF]

				L. M. Olivier, W. Kovacs, K. Masuda, G.-A. Keller, and S. K. Krisans Identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes: AA-CoA thiolase, HMG-CoA synthase, MPPD, and FPP synthase J. Lipid Res., December 1, 2000; 41(12): 1921 - 1935. [Abstract] [Full Text]